Metabolic Brain Disease
Q2 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Biochemistry
Q2
└
Cellular and Molecular Neuroscience
Q2
└
Neurology (clinical)
Q2
Publisher
SJR 2025
0.995
Q2
SJR Score
H-Index
87
Citations / Doc (2yr)
4.18
Total Docs. (latest)
330
Total Citations (3yr)
2,466
Publication type
Journals
ISSN
15737365, 08857490
Coverage
1986-2026
Journal Rank
#4,949
Subject Categories
Biochemistry
Q2
Cellular and Molecular Neuroscience
Q2
Neurology (clinical)
Q2
Subject Areas
Aims & Scope
Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies.
The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies.
Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 330 |
| Total Docs. (3 years) | 555 |
| Total Refs. | 23,319 |
| Total Citations (3 years) | 2,466 |
| Citable Docs. (3 years) | 548 |
| Citations / Doc. (2 years) | 4.18 |
| Ref. / Doc. | 70.66 |
| % Female | 49.1% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.